Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 12-1999 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 551,384 | N/A |
| Marketable Securities | 642,475 | N/A |
| Receivables | 261,682 | N/A |
| Inventories | 265,830 | N/A |
| Income taxes - deferred | 40,619 | N/A |
| TOTAL | $1,793,422 | $N/A |
| Non-Current Assets | ||
| PPE Net | 752,892 | N/A |
| Investments And Advances | 1,265,515 | 0 |
| Intangibles | 2,736,137 | 0 |
| Other Non-Current Assets | 168,458 | 0 |
| TOTAL | $4,923,002 | $N/A |
| Total Assets | $6,716,424 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 39,114 | 0 |
| Accrued Expenses | 12,265 | N/A |
| TOTAL | $453,292 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 149,692 | N/A |
| Deferred Revenues | 15,433 | N/A |
| Other Non-Current Liabilities | 1,789 | 0 |
| TOTAL | $588,929 | $N/A |
| Total Liabilities | $1,042,221 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 10,510 | N/A |
| Retained earnings | -1,319,353 | N/A |
| Other shareholders' equity | 331,618 | 0 |
| TOTAL | $5,674,203 | $N/A |
| Total Liabilities And Equity | $6,716,424 | $0 |